Evidence map›Paper›PMID 23331953›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2013

Racial/ethnic differences in cancer risk after kidney transplantation.

E C Hall, D L Segev, E A Engels

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. CKD and risk of renal cell carcinoma: a causal association?Journal of the American Society of Nephrology : JASN · 2014
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

E C HallDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. ehall@jhsph.edu
D L Segev
E A Engels
Division of Cancer Epidemiology and GeneticsJohns Hopkins University · US

Funding

NAT'L CANCER PREV & CONTROL PROG (COMPONENTS: MI COMPREH CANCER CONTR PROG, MI BRU58DP000812 · DP · MICHIGAN STATE DEPARTMENT OF HEALTH AND HUMAN SERVICES · PI BROOKOVER, PATRICIA · 2007 to 2011
$51.4M
NATIONAL CANCER PREVENTION AND CONTROL PROGRAMU58DP000824 · DP · TEXAS STATE DEPT OF HEALTH SERVICES · PI DELGADO, EVELYN · 2007 to 2011
$44.3M
COMPREHENSIVE CANCER CONTROL; OPTIONAL FUNDING (PROSTATE CANCER); ILLINOIS BREASTU58DP000805 · DP · ILLINOIS STATE DEPT OF PUBLIC HEALTH · PI SCHAFER, THOMAS J. · 2007 to 2011
$37.5M
THE GEORGIA COMPREHENSIVE CANCER PROGRAM TO REDUCE MORTALITYU58DP000817 · DP · GEORGIA STATE DEPT OF HUMAN RESOURCES · PI REDDING, KIMBERLY · 2007 to 2011
$27.1M
Category A - Communities Putting Prevention to WorkU58DP000848 · DP · COLORADO STATE DEPT/PUB HLTH & ENVIRONMT · PI JACOBELLIS, JILLIAN · 2007 to 2011
$25.9M
Infections, immunity, and inflammation in cancerZIACP010150 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2009 to 2025
$24.0M
NATIONAL CANCER PREVENTION AND CONTROL PROGRAMU58DP000832 · DP · NC STATE DEPT/HLTH & HUMAN SERVICES · PI PETERSEN, RUTH · 2007 to 2011
$23.6M
CALIFORNIA'S PARTICIPATION IN THE NATIONAL CANCER PREVENTION AND CONTRO PROGRAMU58DP000807 · DP · PUBLIC HEALTH INSTITUTE · PI SNIPES, KURT P · 2007 to 2011
$22.5M
NPCR-ENHANCEMENT OF EXISTING CANCER REGISTRY NBCCEDP-PROVIDE BREAST $ CERVICAL CAU58DP000808 · DP · NEW JERSEY STATE DEPT/HEALTH/SENIOR SRVS · PI RODRIGUEZ, GLORIA · 2007 to 2011
$21.1M
Clinical and Laboratory Research Training for Surgical OncologistsT32CA126607 · NCI · JOHNS HOPKINS UNIVERSITY · PI CAMERON, ANDREW M. · 2008 to 2024
$6.0M
Infections, immunity, and inflammation in cancerZ01CP010150 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2000 to 2008
$3.0M
Intramural NIH HHS Z01 CP010150NCCDPHP CDC HHS 1U58 DP000807-01NCCDPHP CDC HHS 5658DP000805-04NCCDPHP CDC HHS 5U58/DP000808-05NCCDPHP CDC HHS 5U58DP000812-03NCCDPHP CDC HHS 5U58DP000817-05NCCDPHP CDC HHS 5U58DP000824-04NCCDPHP CDC HHS U58 DP000805NCCDPHP CDC HHS U58 DP000807NCCDPHP CDC HHS U58 DP000808NCCDPHP CDC HHS U58 DP000817NCCDPHP CDC HHS U58 DP000824NCCDPHP CDC HHS U58 DP000832NCCDPHP CDC HHS U58DP000832NCCDPHP CDC HHS U58 DP000848NCCDPHP CDC HHS U58 DP000848-04NCI NIH HHS HHSN261201000027CNCI NIH HHS N01 PC035137NCI NIH HHS N01 PC035139NCI NIH HHS N01 PC035142NCI NIH HHS N01 PC035143NCI NIH HHS N01 PC054405NCI NIH HHS N01-PC-35137NCI NIH HHS N01-PC-35139NCI NIH HHS N01-PC-35142NCI NIH HHS N01-PC-35143NCI NIH HHS N01-PC-54405NCI NIH HHS T32 CA126607NCI NIH HHS T32CA126607
6 · The paper itself

Abstract

Transplant recipients have elevated cancer risk, but it is unknown if cancer risk differs across race and ethnicity as in the general population. US kidney recipients (N = 87,895) in the Transplant Cancer Match Study between 1992 and 2008 were evaluated for racial/ethnic differences in risk for six common cancers after transplantation. Compared to white recipients, black recipients had lower incidence of non-Hodgkin lymphoma (NHL) (adjusted incidence rate ratio [aIRR] 0.60, p<0.001) and higher incidence of kidney (aIRR 2.09, p<0.001) and prostate cancer (aIRR 2.14, p<0.001); Hispanic recipients had lower incidence of NHL (aIRR 0.64, p = 0.001), lung (aIRR 0.41, p < 0.001), breast (aIRR 0.53, p = 0.003) and prostate cancer (aIRR 0.72, p = 0.05). Colorectal cancer incidence was similar across groups. Standardized incidence ratios (SIRs) measured the effect of transplantation on cancer risk and were similar for most cancers (p≥0.1). However, black and Hispanic recipients had larger increases in kidney cancer risk with transplantation (SIRs: 8.96 in blacks, 5.95 in Hispanics vs. 4.44 in whites), and only blacks had elevated prostate cancer risk following transplantation (SIR: 1.21). Racial/ethnic differences in cancer risk after transplantation mirror general population patterns, except for kidney and prostate cancers where differences reflect the effects of end-stage renal disease or transplantation.

Indexed as

AdolescentAdultBlack or African AmericanChildChild, PreschoolFemaleFollow-Up StudiesHispanic or LatinoHumansIncidenceInfantInfant, NewbornKidney DiseasesKidney TransplantationMaleMiddle Aged

Identifiers

PMID23331953
PMCPMC4241757
OpenAlexW1595802007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.